1. Home
  2. SWTX vs OSIS Comparison

SWTX vs OSIS Comparison

Compare SWTX & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • OSIS
  • Stock Information
  • Founded
  • SWTX 2017
  • OSIS 1987
  • Country
  • SWTX United States
  • OSIS United States
  • Employees
  • SWTX N/A
  • OSIS N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • OSIS Industrial Machinery/Components
  • Sector
  • SWTX Health Care
  • OSIS Technology
  • Exchange
  • SWTX Nasdaq
  • OSIS Nasdaq
  • Market Cap
  • SWTX 3.0B
  • OSIS 3.3B
  • IPO Year
  • SWTX 2019
  • OSIS 1997
  • Fundamental
  • Price
  • SWTX $58.25
  • OSIS $202.27
  • Analyst Decision
  • SWTX Strong Buy
  • OSIS Strong Buy
  • Analyst Count
  • SWTX 6
  • OSIS 6
  • Target Price
  • SWTX $70.83
  • OSIS $205.17
  • AVG Volume (30 Days)
  • SWTX 3.2M
  • OSIS 205.6K
  • Earning Date
  • SWTX 02-20-2025
  • OSIS 01-23-2025
  • Dividend Yield
  • SWTX N/A
  • OSIS N/A
  • EPS Growth
  • SWTX N/A
  • OSIS 18.05
  • EPS
  • SWTX N/A
  • OSIS 7.78
  • Revenue
  • SWTX $191,589,000.00
  • OSIS $1,650,140,000.00
  • Revenue This Year
  • SWTX $3,475.18
  • OSIS $12.49
  • Revenue Next Year
  • SWTX $81.60
  • OSIS $5.20
  • P/E Ratio
  • SWTX N/A
  • OSIS $26.07
  • Revenue Growth
  • SWTX 3417.33
  • OSIS 20.69
  • 52 Week Low
  • SWTX $28.21
  • OSIS $126.57
  • 52 Week High
  • SWTX $62.00
  • OSIS $220.00
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 70.71
  • OSIS 54.00
  • Support Level
  • SWTX $54.89
  • OSIS $202.71
  • Resistance Level
  • SWTX $62.00
  • OSIS $220.00
  • Average True Range (ATR)
  • SWTX 4.09
  • OSIS 6.98
  • MACD
  • SWTX 1.35
  • OSIS -0.53
  • Stochastic Oscillator
  • SWTX 85.90
  • OSIS 44.54

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

Share on Social Networks: